Enanta Pharmaceuticals
ENTA
#7679
Rank
S$0.47 B
Marketcap
S$16.40
Share price
0.00%
Change (1 day)
131.79%
Change (1 year)

Market capitalization of Enanta Pharmaceuticals (ENTA)

Market cap: S$0.47 Billion

As of February 2026 Enanta Pharmaceuticals has a market cap of S$0.47 Billion. This makes Enanta Pharmaceuticals the world's 7679th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enanta Pharmaceuticals from 2013 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.47 B-23.8%
2025S$0.62 B260.63%
2024S$0.17 B-33.84%
2023S$0.26 B-79.82%
2022S$1.29 B-37.43%
2021S$2.07 B85.37%
2020S$1.11 B-32.22%
2019S$1.64 B-12.26%
2018S$1.88 B25.28%
2017S$1.50 B62.6%
2016S$0.92 B5.16%
2015S$0.87 B-29.8%
2014S$1.25 B101.4%
2013S$0.62 B

End of Day market cap according to different sources

On Feb 1st, 2026 the market cap of Enanta Pharmaceuticals was reported to be:

S$0.47 Billion
by Nasdaq info icon info icon
S$0.47 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$695.89 B 146,161.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$362.60 B 76,110.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
S$500.96 B 105,190.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$153.12 B 32,084.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$350.07 B 73,477.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$142.44 B 29,837.63%๐Ÿ‡บ๐Ÿ‡ธ USA